Celldex Therapeutics, Inc. (CLDX) Presents At Morgan Stanley 23rd Annual Global Healthcare Conference Transcript

Group 1 - The session is part of the Morgan Stanley Global Healthcare Conference, focusing on the biotech sector [1] - Judah Frommer serves as an equity analyst specializing in SMid biotech [1] - The Celldex team is being welcomed to present their company and lead asset [2] Group 2 - The conference aims to provide insights for those less familiar with Celldex and its offerings [2]